Finafloxacin-d4 (hydrochloride)

Finafloxacin-d4 (hydrochloride)

• CAS Number: 2012598-36-4
• UNSPSC Description: Finafloxacin-d4 (hydrochloride) is deuterium-labeled Finafloxacin (hydrochloride) (HY-13451A)[1].
• Target Antigen: Bacterial; Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Anti-infection;Others
• Applications: COVID-19-immunoregulation
• Field of Research: Infection
• Smiles: O=C(C1=CN(C2C([2H])([2H])C2([2H])[2H])C3=C(C=C(F)C(N4C[C@]5([H])OCCN[C@@]5([H])C4)=C3C#N)C1=O)O.Cl
• Molecular Weight: 438.87
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Smith K A, et al. Soil and environmental analysis[M]. Marcel Dekker Incorporated, 2000.|[3]Fan T W M, et al. Stable isotope-resolved metabolomics and applications for drug development[J]. Pharmacology & therapeutics, 2012, 133(3): 366-391.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported